The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Ian E. Smith

Breast Unit

Royal Marsden Hospital

London

and the Institute of Cancer Research

UK

[email]@rmh.nhs.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Breast Unit, Royal Marsden Hospital, London, and the Institute of Cancer Research, UK. 2006 - 2011
  • Breast Unit, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK. 2005 - 2008

References

  1. First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients. Smith, I.E., Pierga, J.Y., Biganzoli, L., Cortés-Funes, H., Thomssen, C., Pivot, X., Fabi, A., Xu, B., Stroyakovskiy, D., Franke, F.A., Kaufman, B., Mainwaring, P., Pienkowski, T., De Valk, B., Kwong, A., González-Trujillo, J.L., Koza, I., Petrakova, K., Pereira, D., Pritchard, K.I. Ann. Oncol. (2011) [Pubmed]
  2. Targeting HER2 in the adjuvant setting: dealing with new standards and with open questions. Smith, I.E. Breast (2009) [Pubmed]
  3. The follow-up of women at high risk for breast cancer relapse. Smith, I.E., Banerjee, S. Breast (2009) [Pubmed]
  4. Do BIG1-98 and ZOFAST demand a change in guidelines for endocrine therapy?. Smith, I.E. Breast Cancer Res. (2009) [Pubmed]
  5. Debate: tailored targeted therapy for all--a realistic and worthwhile objective? Introduction to Session 2. Smith, I.E. Breast Cancer Res. (2009) [Pubmed]
  6. Neoadjuvant/presurgical treatments. Smith, I.E. Breast Cancer Res. (2008) [Pubmed]
  7. The evolution of adjuvant endocrine therapy: developments since St Gallen 2005. Smith, I.E., Arnedos, M. Breast (2007) [Pubmed]
  8. A phase II placebo-controlled trial of neoadjuvant anastrozole alone or with gefitinib in early breast cancer. Smith, I.E., Walsh, G., Skene, A., Llombart, A., Mayordomo, J.I., Detre, S., Salter, J., Clark, E., Magill, P., Dowsett, M. J. Clin. Oncol. (2007) [Pubmed]
  9. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Smith, I., Procter, M., Gelber, R.D., Guillaume, S., Feyereislova, A., Dowsett, M., Goldhirsch, A., Untch, M., Mariani, G., Baselga, J., Kaufmann, M., Cameron, D., Bell, R., Bergh, J., Coleman, R., Wardley, A., Harbeck, N., Lopez, R.I., Mallmann, P., Gelmon, K., Wilcken, N., Wist, E., Sánchez Rovira, P., Piccart-Gebhart, M.J. Lancet (2007) [Pubmed]
  10. Goals of treatment for patients with metastatic breast cancer. Smith, I. Semin. Oncol. (2006) [Pubmed]
  11. Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines. Smith, I.E., Dowsett, M., Yap, Y.S., Walsh, G., Lønning, P.E., Santen, R.J., Hayes, D. J. Clin. Oncol. (2006) [Pubmed]
  12. Overview of gemcitabine activity in advanced breast cancer. Smith, I.E. Semin. Oncol. (2006) [Pubmed]
  13. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial. Smith, I.E., Dowsett, M., Ebbs, S.R., Dixon, J.M., Skene, A., Blohmer, J.U., Ashley, S.E., Francis, S., Boeddinghaus, I., Walsh, G. J. Clin. Oncol. (2005) [Pubmed]
 
WikiGenes - Universities